MedTrace Logo

Clinical and Molecular Investigations Into Ciliopathies

NCT00068224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 374

Last updated 2021-02-21

No results posted yet for this study

Summary

This study will evaluate patients ciliopathies. People with ciliopathies develop fibrocystic disease of the kidneys and liver, retinal degeneration, obesity, structural and functional defects of the central nervous system and the eyes, abnormal bone growth, abnormal sidedness of internal organs and polydactyly. The goal of the study is to better understand the medical complications of these disorders and identify characteristics that can help in the design of new treatments.

Conditions

  • Ciliopathy

Sponsors & Collaborators

  • National Human Genome Research Institute (NHGRI)

    lead NIH

Principal Investigators

  • Meral Gunay-Aygun, M.D. · National Human Genome Research Institute (NHGRI)

Eligibility

Min Age
5 Months
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-16
Primary Completion
2019-10-16
Completion
2021-02-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00068224 on ClinicalTrials.gov